Effect of iron chelator deferasirox on chronic anemia and thrombocytopenia in a transfusion-dependent patient with myelodysplastic syndrome.
Nishiuchi
Takamasa
T
Okutani
Yuichi
Y
Fujita
Toshikazu
T
Yoshida
Kazuya
K
Ohnishi
Hiroaki
H
Haba
Reiji
R
D000368:Aged; D000740:Anemia / Q000628:therapy*; D001565:Benzoates / Q000008:administration & dosage*; D002908:Chronic Disease; D000077588:Deferasirox; D005260:Female; D006801:Humans; D007502:Iron Chelating Agents / Q000008:administration & dosage; D019190:Iron Overload / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D011859:Radiography; D013921:Thrombocytopenia / Q000628:therapy*; D065227:Transfusion Reaction; D014230:Triazoles / Q000008:administration & dosage*
D001565:Benzoates; D007502:Iron Chelating Agents; D014230:Triazoles; D000077588:Deferasirox